J. Goldman & Co LP - NEOS THERAPEUTICS INC ownership

NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 84 filers reported holding NEOS THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.

Quarter-by-quarter ownership
J. Goldman & Co LP ownership history of NEOS THERAPEUTICS INC
ValueSharesWeighting
Q1 2019$313,000
-71.5%
120,000
-82.0%
0.02%
-78.8%
Q4 2018$1,099,000
-86.4%
666,000
-59.9%
0.08%
-84.9%
Q3 2018$8,058,000
-25.0%
1,661,420
-3.3%
0.56%
+1.6%
Q2 2018$10,737,000
+4.4%
1,717,983
+38.7%
0.55%
+26.5%
Q1 2018$10,284,000
+8.6%
1,239,000
+33.5%
0.44%
-11.9%
Q4 2017$9,466,000
+62.7%
928,000
+45.9%
0.50%
+69.6%
Q3 2017$5,818,000
-5.7%
635,865
-24.7%
0.29%
-12.3%
Q2 2017$6,169,000845,0000.33%
Other shareholders
NEOS THERAPEUTICS INC shareholders Q4 2017
NameSharesValueWeighting ↓
DSC Advisors, L.P. 1,043,770$7,620,0002.51%
Stonepine Capital Management, LLC 565,100$4,125,0002.23%
DAFNA Capital Management LLC 209,873$1,532,0001.09%
Ghost Tree Capital, LLC 500,000$3,650,0000.76%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,459,195$10,652,0000.57%
PURA VIDA INVESTMENTS, LLC 150,000$1,095,0000.44%
J. Goldman & Co LP 845,000$6,169,0000.33%
ESSEX INVESTMENT MANAGEMENT CO LLC 191,729$1,400,0000.20%
Opaleye Management Inc. 50,000$365,0000.15%
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC 50,000$365,0000.15%
View complete list of NEOS THERAPEUTICS INC shareholders